Company intelligence / Profile preview

ExoTop Theragnostics, Inc.

Pasadena, California, United Statesexotoptheragnostics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

ExoTop Theragnostics is developing proprietary therapeutic delivery vesicle technology leveraging exosomes for targeted drug delivery. The company appears to be in the preclinical stage with intellectual property focused on enhancing extracellular vesicle production and their use as biopharmaceutical carriers for indications such as cancer[3].

Therapeutic areas: Oncology
Modalities: Extracellular vesicles (exosomes)Biopharmaceuticals[3]
Industry: Biotech

Partnerships

No major partnerships publicly disclosed as of May 2025.

Beyond the preview

Go deeper on ExoTop Theragnostics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoTop Theragnostics, Inc..

Explore the full profile